换一批Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.
第一作者：
Leslie,Randall
作者：
医学主题词
人类(Humans);女(雌)性(Female);宫颈肿瘤(Uterine Cervical Neoplasms);中年人(Middle Aged);双盲法(Double-Blind Method);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);顺铂(Cisplatin);生活质量(Quality of Life);肿瘤分期(Neoplasm Staging)
DOI
10.1016/j.ygyno.2025.06.003
PMID
40592026
发布时间
2026-05-20
- 浏览0
Gynecologic oncology
88-95页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
